Janssen Pharmaceutical K.K. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Date: November 17, 2014
Pages: 19
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: J3B48DF24A6EN
Leaflet:

Download PDF Leaflet

Janssen Pharmaceutical K.K. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary

Janssen Pharmaceutical K.K. (Janssen Pharmaceutical) is a pharmaceutical company. The company develops, imports and exports pharmaceuticals and quasi-drugs. Its products include antipsychotic; oral antifungal agents; antifungal agents for injection; antipsychotic agents; antidepressant, such as serotonin-noradrenaline reuptake inhibitors; therapeutic agent for Alzheimer’s disease; and others. Janssen Pharmaceutical provides services in medical areas, such as central nervous system area, analgesic and aesthetics area, HIV/AIDS, mycosis, and oncology and immunity, among others. The company operates through three distribution centers and five sales offices. It operates as a subsidiary of Johnson & Johnson Co. Janssen Pharmaceutical is headquartered in Chiyoda-ku, Tokyo, Japan.

Janssen Pharmaceutical K.K. - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
  • The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
  • The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
  • Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
  • The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
  • Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
  • Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company.
Janssen Pharmaceutical K.K., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Janssen Pharmaceutical K.K., Pharmaceuticals & Healthcare Deals By Type, 2008 to YTD 2014
Janssen Pharmaceutical K.K., Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014
Janssen Pharmaceutical K.K., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2008 to YTD 2014
Janssen Pharmaceutical K.K., Pharmaceuticals & Healthcare, Deals Summary, 2008 to YTD 2014
Janssen Pharmaceutical K.K., Pharmaceuticals & Healthcare, Deal Details
Partnerships
AstraZeneca Enters Into Co-Promotion Agreement With Janssen For Abiraterone Acetate
Takeda Pharma Enters Into Co-Promotion Agreement With Janssen Pharma
Takeda Enters Into Co-Marketing Agreement With Janssen Pharma And Janssen Pharmaceutica
Licensing Agreements
Forest Labs Enters Into Licensing Agreement With Janssen Pharma For Bystolic And Savella
Janssen Pharmaceutical K.K. - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Janssen Pharmaceutical K.K., Pharmaceuticals & Healthcare, Key Facts
Janssen Pharmaceutical K.K., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Janssen Pharmaceutical K.K., Pharmaceuticals & Healthcare Deals By Type, 2008 to YTD 2014
Janssen Pharmaceutical K.K., Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014
Janssen Pharmaceutical K.K., Deals By Therapy Area, 2008 to YTD 2014
Janssen Pharmaceutical K.K., Pharmaceuticals & Healthcare, Deals Summary, 2008 to YTD 2014
AstraZeneca Enters Into Co-Promotion Agreement With Janssen For Abiraterone Acetate
Takeda Pharma Enters Into Co-Promotion Agreement With Janssen Pharma
Takeda Enters Into Co-Marketing Agreement With Janssen Pharma And Janssen Pharmaceutica
Forest Labs Enters Into Licensing Agreement With Janssen Pharma For Bystolic And Savella
Janssen Pharmaceutical K.K., Key Competitors
Janssen Pharmaceutical K.K., Key Employees
Janssen Pharmaceutical K.K., Other Locations

LIST OF FIGURES

Janssen Pharmaceutical K.K., Pharmaceuticals & Healthcare, Deals by Type, 2008 to YTD 2014
Janssen Pharmaceutical K.K., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Janssen Pharmaceutical K.K., Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014
Janssen Pharmaceutical K.K., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2008 to YTD 2014
Janssen Pharmaceutical K.K., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Janssen Pharmaceutical K.K., Pharmaceuticals & Healthcare, Deals by Type, 2008 to YTD 2014
Janssen Pharmaceutical K.K., Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014
Janssen Pharmaceutical K.K., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2008 to YTD 2014
Skip to top


Ask Your Question

Janssen Pharmaceutical K.K. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: